Cell & Cellular Life Sciences Journal (CCLSJ)

ISSN: 2578-4811

Mini Review

Drug Discovery - Yesterday and Tomorrow: The Common Approaches in Drug Design and Cancer

Authors: Hamad ON*, Amran SIB and Sabbah AM

DOI: 10.23880/cclsj-16000119

Abstract

The process of drug discovery has undergone radical changes and development over years. Traditionally, the drugs were discovered by employing chemistry and pharmacology-based cautious approach. When natural products were the most important source of drugs or drug precursors, but the conventional randomized drug research phenomenon was no longer effective at that time due to many negatives of these approaches like: high expenses of discovering new drugs, time-consuming and reduced success guarantee. Thus, with the development of the era, the concept of “Rational Drug Design” has enabled drug target identification and validation to be more specific. In addition, several novel technologies and approaches have been introducing economics, proteomics and other omics areas such as 3D QSAR, pharmacophore modeling and other, which playing a promising role in accelerating the pace of drug discovery process. Their view of the current research focuses on the importance of drug discovery in modern times and shows how old methods have been replaced and summarized. Some of examples of molecules are identified in addition to computational approaches used to discover it, specifically in the field of anticancer drug design

Keywords:

Drug Discovery; Drug Design; CADD Technologies; 3D QSAR; Pharmacophore Modeling; Computational Methods for Anticancer Drug

View PDF

Google_Scholar_logo Academic Research index asi ISI_logo logo_wcmasthead_en scilitLogo_white F1 search-result-logo-horizontal-TEST cas_color europub infobase logo_world_of_journals_no_margin